Hansoh Pharmaceutical Group Company Limited Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited

3692

주식 순위 #902
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
주가
$4.40
시가총액
$26.66B
변동 (1일)
8.32%
변동 (1년)
-6.19%
국가
CN
거래 Hansoh Pharmaceutical Group Company Limited (3692)

카테고리

Healthcare
Hansoh Pharmaceutical Group Company Limited (3692)의 배당 수익률 기록
Hansoh Pharmaceutical Group Company Limited (주식 심볼: 3692)의 배당 수익률 (TTM)은 2023-12-31 기준으로 0.73%입니다.
지난 5년 평균 배당 수익률: 1.25%
Hansoh Pharmaceutical Group Company Limited (3692)의 배당 수익률 기록: 2016 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
2026 (TTM) 1.54% -20.21%
2024 1.93% 164.38%
2023 0.73% -20.65%
2022 0.92% 119.05%
2021 0.42% -81.42%
2020 2.26% 91.53%
2019 1.18% 0.00%
2018 0.00% -100.00%
2017 0.44% -81.51%
2016 2.38% 0.00%
유사 기업 또는 경쟁사의 배당 수익률 (TTM)